Drug intelligence / Profile preview

Proliverenol

Development stage
Phase 2
Lead developer
Dexa Medica
Modality
Small Molecules
Administration
Oral
01

Overview

Proliverenol is a bioactive fraction derived from the dried fruit of Phaleria macrocarpa (Scheff.) Boerl, an Indonesian herbal plant. It is being investigated primarily for its hepatoprotective properties, particularly in the context of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis. The proposed mechanisms of action include anti-inflammatory effects, DNA repair facilitation, anti-apoptotic activity, antioxidant effects (amelioration of oxidative stress), and regulation of pro-fibrogenic cytokines such as Transforming growth factor beta 1 (TGF-β1) and antifibrotic markers like Matrix metalloproteinase 13 (MMP-13). Preclinical studies have shown that Proliverenol can normalize liver function tests and reduce markers of oxidative stress and fibrosis in animal models[1][2][3][6][7][8]. Clinical trials are ongoing to evaluate its efficacy in patients with NAFLD.

Brand names
proliverenol
Other names
Phaleria macrocarpa extractmahkota dewa extract
02

Targets

TGFB1 (Transforming growth factor Beta-1 proprotein)MMP13 (Matrix metalloproteinase-13)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on Proliverenol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proliverenol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call